USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS

Objective: To evaluate the impact of rituximab (RTM) therapy on the clinical, morphological, and immunological parameters of lupus nephritis (LN) activity. Subjects and methods. The study included 19 patients with types III and IV LN (WHO classification) with its 6-133-month history. Their mean age...

Full description

Bibliographic Details
Main Authors: Anna Vasilyevna Torgashina, S K Solovyev, E N Aleksandrova, S G Radenska-Lopovok, E L Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2010-08-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1075